首页> 外国专利> orally applicable once daily extended release form for treatment of hypertension with diltiazemhydrochlorid.

orally applicable once daily extended release form for treatment of hypertension with diltiazemhydrochlorid.

机译:口服适用于每日一次延长释放形式,用于盐酸地尔硫卓的高血压治疗。

摘要

Pharmaceutical units does contains 90-270mg diltiazem hydrochloride (I); has in vitro release rate 20-70%, 35-85% and 50-100% after 1,2 and 3.5 hr. , respectively, with at least 60% released after 5hr.; and are used for treatment of hypertension by once-daily oral administration. Pref. the dose contains 180mg (I) and releases at least85% after 5 hr.; im vitro.
机译:制药单位含有90-270mg盐酸地尔硫卓(I);在1,2和3.5小时后,其体外释放率为20-70%,35-85%和50-100%。分别在5小时后释放至少60%。每天口服一次,可用于治疗高血压。首选该剂量含有180mg(I),并在5小时后释放至少85%;体外。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号